Jushi Holdings (JUSHF) Other Working Capital Changes (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Other Working Capital Changes of -$326000.0 for Q2 2026, down 182.12% year-over-year from $397000.0 in Q2 2025, and up 36.33% quarter-over-quarter from -$512000.0 in Q1 2026.
Jushi Holdings (JUSHF) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Other Working Capital Changes for 6 consecutive years, with -$326000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Working Capital Changes fell 182.12% year-over-year to -$326000.0; the TTM figure through Jun 2026 stood at -$1.6 million (down 251.04% YoY), while the FY2025 annual figure was -$1.2 million, down 175.96% from the prior year.
- Other Working Capital Changes improved to -$326000.0 in Q2 2026 per JUSHF's latest filing, from -$512000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.1 million in Q2 2023 and bottomed at -$3.0 million in Q1 2023.
- Historically, Other Working Capital Changes has averaged -$144944.4 across 5 years, with a median of -$419000.0 in 2026.
- On a YoY basis, Other Working Capital Changes climbed as much as 397.09% in 2024 and fell as far as 471.88% in 2024.
- Jushi Holdings' Other Working Capital Changes stood at $892000.0 in 2022, then plunged by 82.06% to $160000.0 in 2023, then tumbled by 471.88% to -$595000.0 in 2024, then soared by 89.41% to -$63000.0 in 2025, then sank by 417.46% to -$326000.0 in 2026.
- Business Quant data shows JUSHF's Other Working Capital Changes at -$326000.0 in Q2 2026, -$512000.0 in Q1 2026, and -$63000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -326,000.00 |
| Jun 30, 2026 | -326,000.00 |
| Jun 30, 2026 | -326,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |